LNSR
LENSARCNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-03
Current thesis
The operating backdrop is better than a typical busted-deal micro-cap: March 31 disclosures showed continued ALLY placements, a larger installed base, 22% annual procedure growth, and recurring revenue at 79% of sales, while the company kept the $10 million merger deposit and added a sizable credit facility [#PR-2026-03-31] [#8-K-2026-03-16] [#8-K-2026-03-12].
Posture
Mixed
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite.
What can break
ALLY placements or procedure growth may slow once the company operates fully on a standalone basis
Momentum
68
Value
36
Sentiment
44
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $5.60 · Bull $8.50 · Bear $3.60
Data freshness
Prices
As of 2026-06-03
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-03 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-17 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-03
Investment thesis
As of 2026-06-03
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $10.00
Why
Momentum68 · Δ7d -
Value36 · Δ7d -0.0
Sentiment44 · Δ7d -
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Momentum · See technicals
Momentum
68
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
36
32% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
44
33% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade C. Momentum 67.9 / Value 36.3 / Sentiment 43.8
Fundamentals (TTM)As of 2026-06-02
Fundamentals (TTM)
As of 2026-06-02
Market Cap
$69.48M
Beta
0.69
Shares Out
11.94M
P/E (TTM) · Derived
-2.1
P/S (TTM)
2.27
P/FCF (TTM) · Derived
-5.80
Rev YoY
+5.7%
EPS YoY
-138.2%
Gross Margin
+46.1%
Op Margin
-35.4%
Net Debt
-$22.46M
Current Ratio
1.24
As of 2026-06-03 • Updated nightlySource: Internal modelMethodology